Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves over-expression of Cyr61

Toxicology in Vitro

Volumn 25, Issue 1, 2011, Pages 199-205

  Lee, Yoon Jin ^a   Lee, David M ^b   Lee, Chang Ho ^a   Heo, Sue Hak ^a   Won, Seong Youn ^a   Im, Jae Hyuk ^a   Cho, Moon Kyun ^a   Nam, Hae Seon ^a   Lee, Sang Han ^a  

^a Soonchunhyang University   (South Korea)

^b Poolesville High School   (United States)

Author keywords

Antioxidants; Cyr61; N acetylcysteine; Pro oxidant; Prostate cancers; ROS

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLCYSTEINE; ANDROGEN; CYCLOHEXIMIDE; CYSTEINE RICH PROTEIN 61; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CANCER INHIBITION; CARCINOMA CELL; CELL LINE; CELL PROLIFERATION; CELL STRAIN PC3; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; PROSTATE CANCER; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYSTEINE-RICH PROTEIN 61; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; I-KAPPA B KINASE; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78650517946     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.10.020     Document Type: Article

References (36)

1. Babic A.M., Kireeva M.L., Kolesnikova T.V., Lau L.F. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 1998, 95:6355-6360.
2. Davies K.J. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999, 48:41-47.
3. Franzen C.A., Chen C.C., Todorović V., Juric V., Monzon R.I., Lau L.F. Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis. Mol. Cancer Res. 2009, 7:1045-1055.
4. Giménez-Bonafé P., Tortosa A., Pérez-Tomás R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr. Cancer Drug Targets 2009, 9:320-340.
5. Han B., Wei W., Hua F., Cao T., Dong H., Yang T., Yang Y., Pan H., Xu C. Requirement for ERK activity in sodium selenite-induced apoptosis of acute promyelocytic leukemia-derived NB4 cells. J. Biochem. Mol. Biol. 2007, 40:196-204.
6. Havre P.A., O'Reilly S., McCormick J.J., Brash D.E. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetylcysteine and penicillamine. Cancer Res. 2002, 62:1443-1449.
7. Hilfiker-Kleiner D., Kaminski K., Kaminska A., Fuchs M., Klein G., Podewski E., Grote K., Kiian I., Wollert K.C., Hilfiker A., Drexler H. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 2004, 109:2227-2233.
8. Hussain A.R., Ahmed M., Al-Jomah N.A., Khan A.S., Manogaran P., Sultana M., Abubaker J., Platanias L.C., Al-Kuraya K.S., Uddin S. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol. Cancer Ther. 2008, 7:3318-3329.
9. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2008, 58:71-96.
10. Kelly G.S. Clinical applications of N-acetylcysteine. Altern. Med. Rev. 1998, 3:114-127.
11. Khan N.S., Ahmad A., Hadi S.M. Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chem. Biol. Interact. 2000, 125:177-189.
12. Kusano C., Takao S., Noma H., Yoh H., Aikou T., Okumura H., Akiyama S., Kawamura M., Makino M., Baba M. N-acetyl cysteine inhibits cell cycle progression in pancreatic carcinoma cells. Hum. Cell 2000, 13:213-220.
13. Leu S.J., Lam S.C., Lau L.F. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J. Biol. Chem. 2002, 277:46248-46255.
14. Li W., Nie S., Yu Q., Xie M. (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J. Agric. Food Chem. 2009, 57:6685-6691.
15. Li Y.Q., Zhang Z.X., Xu Y.J., Ni W., Chen S.X., Yang Z., Ma D. N-Acetyl-l-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms. Acta Pharmacol. Sin. 2006, 27:339-346.
16. Lim Y.C., Park H.Y., Hwang H.S., Kang S.U., Pyun J.H., Lee M.H., Choi E.C., Kim C.H. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett. 2008, 271:140-152.
17. Liu M., Pelling J.C., Ju J., Chu E., Brash D.E. Antioxidant action via p53-mediated apoptosis. Cancer Res. 1998, 58:1723-1729.
18. Mabuchi S., Ohmichi M., Kimura A., Hisamoto K., Hayakawa J., Nishio Y., Adachi K., Takahashi K., Arimoto-Ishida E., Nakatsuji Y., Tasaka K., Murata Y. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J. Biol. Chem. 2002, 277:33490-33500.
19. Menon S.G., Sarsour E.H., Kalen A.L., Venkataraman S., Hitchler M.J., Domann F.E., Oberley L.W., Goswami P.C. Superoxide signaling mediates N-acetyl-l-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res. 2007, 67:6392-6399.
20. Moro L., Arbini A.A., Marra E., Greco M. Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int. J. Oncol. 2007, 30:217-224.
21. Moss R.W. Do antioxidants interfere with radiation therapy for cancer?. Integr. Cancer Ther. 2007, 6:281-292.
22. Noonan D.M., Benelli R., Albini A. Angiogenesis and cancer prevention: a vision. Recent Results Cancer Res. 2007, 174:219-224.
23. Pasciu V., Posadino A.M., Cossu A., Sanna B., Tadolini B., Gaspa L., Marchisio A., Dessole S., Capobianco G., Pintus G. Akt down regulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants. Toxicol. Sci. 2010, 114:101-112.
24. Plo I., Bettaïeb A., Payrastre B., Mansat-De Mas V., Bordier C., Rousse A., Kowalski-Chauvel A., Laurent G., Lautier D. The phosphoinositide 3-kinase/Akt pathway is activated by daunorubicin in human acute myeloid leukemia cell lines. FEBS Lett. 1999, 452:150-154.
25. Sekharam M., Trotti A., Cunnick J.M., Wu J. Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine. Toxicol. Appl. Pharmacol. 1998, 149:210-216.
26. Shukla S., Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Clin. Cancer Res. 2004, 10:3169-3178.
27. Syng-Ai C., Kumari A.L., Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther. 2004, 3:1101-1108.
28. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.
29. Tang D., Okada H., Ruland J., Liu L., Stambolic V., Mak T.W., Ingram A.J. Akt is activated in response to an apoptotic signal. J. Biol. Chem. 2001, 276:30461-30466.
30. Todorovicç V., Chen C.C., Hay N., Lau L.F. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J. Cell Biol. 2005, 171:559-568.
31. Tsai M.S., Bogart D.F., Castañeda J.M., Li P., Lupu R. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002, 21:8178-8185.
32. Tsai M.S., Hornby A.E., Lakins J., Lupu R. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res. 2000, 60:5603-5607.
33. Tuttle S., Horan A.M., Koch C.J., Held K., Manevich Y., Biaglow J. Radiation-sensitive tyrosine phosphorylation of cellular proteins: sensitive to changes in GSH content induced by pretreatment with N-acetyl-l-cysteine or l-buthionine-S,R-sulfoximine. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:833-838.
34. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 2000, 275:39435-39443.
35. Wlodek L. Beneficial and harmful effects of thiols. Pol. J. Pharmacol. 2002, 54:215-223.
36. 3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J. Biol. Chem. 2000, 275:24565-24574.